Start your Trading & Investing Journey with us
Join our channel for Daily Free Trades with Live analysis on Youtube, Trade Setup with Important Levels, and Important Stock Market Updates
Anthem Biosciences IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details
Anthem Biosciences IPO: Comprehensive Peer Comparison with CRDMO Companies
This peer comparison evaluates Anthem Biosciences IPO against key competitors like Syngene International Limited, Sai Life Sciences Limited, Cohance Lifesciences Limited (Formerly Suven Pharmace uticals) and Divi’s Laboratories Limited. By analysing essential financial metrics such as EPS, ROCE, ROE, P/E ratio, P/Bv, and Debt/Equity, investors can gain insights into the relative performance and valuation of these CRDMO Company. This comparison highlights the strengths and positioning of Anthem Biosciences in the competitive landscape of the CRDMO Industry.
Anthem Biosciences Limited IPO Peer Comparison
| Company Name | EPS | P/E (x) | ROE | ROCE | P/BV | Debt/Equity | RoNW (%) |
|---|---|---|---|---|---|---|---|
| Anthem Biosciences Limited | ₹ 8.04 | 70.94 | 20.82 % | 27.64 % | 13.23 | 0.05 | 20.82 % |
| Syngene International Limited | ₹ 12.3 | 54.1 | 10.5 % | 13.5 % | 5.42 | 0.12 | 10.5 % |
| Sai Life Sciences Limited | ₹ 8.32 | 94.5 | 10.9 % | 13.9 % | 7.54 | 0.13 | 10.9 % |
| Cohance Lifesciences Limited (Formerly Suven Pharmaceuticals) | ₹ 10.5 | 144 | 14.1 % | 16.8 % | 14.9 | 0.16 | 14.1 % |
| Divis Laboratories Limited | ₹ 82.5 | 83.3 | 15.4 % | 20.4 % | 12.2 | 0.00 | 15.4 % |
© 2022 CA Abhay Varn. All Rights Reserved Abhayvarn.com
